From 1 to 14 July 2015 IMI will hold webinars on each topic of the IMI2 5th Call for proposals, as well as on IMI2 rules and procedures.

All webinars on the Call topics will feature a presentation by the EFPIA topic coordinator, as well as time for questions and answers. The webinars therefore represent an excellent opportunity to learn more about the topics, interact directly with the topic coordinators, and get in touch with potential project partners.

The webinar on IMI’s new rules and procedures will also include presentations of IMI's intellectual property policy and tips on the preparation of proposal submissions.

Webinar schedule:

Patient perspective elicitation on benefits and risks of medicinal products from development through the entire life cycle, for integration into benefit risk assessments by regulators and health technology assessment bodies

Wednesday 1 July 2015, 15:00 - 17:00 CEST (Brussels time)

Apolipoprotein E (ApoE) biology to validated Alzheimer’s disease targets

Thursday 2 July 2015, 14:30 - 16:30 CEST (Brussels time)

Inflammation and Alzheimer’s disease (AD): modulating microglia function – focussing on TREM2 and CD33

Friday 3 July 2015, 14:30 - 16:30 CEST (Brussels time)

Understanding the role of amyloid biomarkers in the current and future diagnosis and management of patients across the spectrum of cognitive impairment (from pre-dementia to dementia)

Monday 6 July 2015, 15:00 - 17:00 CEST (Brussels time)

Diabetic kidney disease biomarkers (DKD-BM)

Wednesday 8 July 2015, 15:30 - 17:30 CEST (Brussels time)

IMI2 - New rules and procedures for IMI Calls for proposals

Thursday 9 July 2015, 14:30 - 16:30 CET (Brussels time)

Evolving models of patient engagement and access for earlier identification of Alzheimer’s disease: phased expansion study

Tuesday 14 July 2015, 14:30 - 16:30 CEST (Brussels time)

For further information please visit

webinars-imi2-call-5-topics

future-topics